Recent Articles

November 11, 2014 10:51 am
Cynthia Fox, Science Editor
“Berlin Patient” Timothy Brown was cured of HIV after he received stem cells from a patient naturally immune to the disease. His story inspired two companies to try and recreate that natural immunity in HIV patients using stem cells and two (then-new) gene-editing techniques. Read more...
November 7, 2014 4:48 pm
Drug, Discovery & Development Staf
Our editors searched for trending topics from leading scientific journals that will have you talking at the water cooler and sending them out via social media to friends and colleagues. Read more...
November 5, 2014 5:29 pm
Stephanie Guzowski, Editor
After months of delayed, fragmented responses, the international medical community recognized Ebola as a threat to global health security. Here’s where the situation stands today as well as questions raised and lessons learned. Read more… 
November 4, 2014 2:07 pm
Ryan Bushey, Associate Editor
Google is working on a slew of ambitious projects that could drastically revolutionize healthcare as we know it. Read more...                       
November 4, 2014 10:17 am
Christina Mack, Ph.D., MSPH, Associate Director, Epidemiology, Real-World & Late Phase Research, Quintiles, and Kathy Lang, Ph.D., Senior Director, Emerging Businesses Data & Analytics, Real-World & Late Phase Research, Quintiles
Biopharma is increasingly harnessing the power of data collected outside of a controlled clinical environment to generate valuable insights to support products throughout their lifecycle. Read more...
November 3, 2014 11:04 am
Philip MacLaughlin, Product Director, PharmaPendium
Unanticipated adverse drug-drug interactions (DDIs) have led to the withdrawal of several high-profile drugs that had been available for a number of years, including terfenadine, astemizole, cisapride, grepafloxacin and mibefradil.  Read more... 
October 31, 2014 11:22 am
Cynthia Fox, Science Editor
The most potent stem cells are coming to patients after helping blind (and nearly blind) mice see for years. Read more...                                                                                
October 29, 2014 12:20 pm
Neil Canavan
Since cancer immunotherapy was declared the Breakthrough of the Year in 2013 by Science magazine the field has been on fire, and its relatively few experts have been on the run– explaining the nascent technology and related data to oncologists at venues from the April meeting of AACR in San Diego, to the June meeting of ASCO in Chicago, to the September meeting of ESMO in Madrid.  Read more...
October 27, 2014 4:01 pm
Chandreyee Das, Ph.D., Senior Technical Writer, Protein Detection, EMD Millipore
Many biological samples in the course of drug development research are rich in lipid content, such as adipose tissue homogenates, brain and liver tissue extracts, lipemic samples and breast milk. Read more...
October 20, 2014 4:08 pm
Cynthia Fox, Science Editor
As San Diego’s ViaCyte was in the midst of launching the first FDA-approved embryonic stem (ES) cell clinical trial for diabetes last week, Boston’s Harvard University reported that beta cells from ES cells “cured” diabetic mouse-models. Read more...
Subscribe to Drug Discovery & Development